What is driving TSLA stock today?

News around the Elon Musk trial is adding headline risk, while technicals show soft momentum. Price sits near the 200-day average, so traders are watching $392 to $402. Broader tech sentiment and USD strength also affect returns for Australians trading in AUD.

How could the Elon Musk trial affect Tesla investors?

The shareholder class action over alleged Twitter market manipulation can distract leadership and raise regulatory attention. Even without direct financial penalties for Tesla, headlines can sway risk appetite. This can lift volatility and pressure multiples until testimony ends and outcomes are clearer.

What key technical levels should I watch on TSLA?

Focus on the 200-day near $391.83 as support and the Bollinger lower band around $392.77. On the upside, monitor $410, then $420 to $430 near the 50-day at $429.85. ATR at 14.13 suggests wider daily moves, so size positions accordingly.

When is Tesla’s next earnings report?

The next scheduled earnings announcement is 21 April 2026 at 21:00 UTC. Traders will look for delivery trends, margin updates, energy storage progress, and AI-related spending. Guidance will likely influence valuation far more than near-term headline noise from the ongoing trial.

How should Australians manage currency risk with TSLA?

TSLA trades in USD, so AUD movements can change your local return. Check FX spreads and consider partial hedging if your holding period is short. For longer horizons, many accept currency swings but size positions so FX volatility does not dominate portfolio risk.

Global Market Insights

TSLA Stock Today: March 9 – Musk’s Twitter Trial Weighs on Sentiment

ByDanny Kontos March 9, 2026March 9, 2026

TSLA stock today is under a cloud as Elon Musk’s courtroom testimony in a shareholder class action over alleged Twitter market manipulation raises headline risk. For Australian investors, Nasdaq: TSLA remains USD‑denominated, so FX swings can amplify returns. At the last available close, shares were $396.73, down 2.17%, with momentum soft and volatility elevated. We break down the trial’s market impact, key technical levels, valuation signals, and the next earnings date so you can set clear risk limits and position sizing.